Internal Medicine, Cardiovascular Disease · Lubbock, TX
NPI
1477583052
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
4001 21st St
Lubbock, TX, 79410
Phone (806) 797-4774
Groups this clinician bills Medicare through
Medicare paid, 2024
$572K
22,706 services
Medicare patients, 2024
422
Average age 75
Drug cost, 2024
$767K
10,430 prescriptions
Company payments, 2025
$336
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ayman Karkoutly was code 99214 (office e&m - established), 1,373 times for 408 patients. In total Ayman Karkoutly billed 22,706 services in 84 codes, and Medicare paid $572K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,373 | 408 | $77.15 | $106K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,143 | 267 | $4.52 | $5,164 |
| 93000 Electrocardiogram | Office | 1,124 | 413 | $8.52 | $9,572 |
| 80048 Clinical Chemistry | Office | 1,116 | 409 | $8.16 | $9,104 |
| 84484 Clinical Chemistry | Office | 1,115 | 408 | $11.99 | $13K |
| 82553 Clinical Chemistry | Office | 1,115 | 408 | $11.11 | $12K |
| 80076 Clinical Chemistry | Office | 1,115 | 409 | $7.88 | $8,787 |
| 83880 Clinical Chemistry | Office | 1,114 | 408 | $37.87 | $42K |
| 84436 Clinical Chemistry | Office | 1,114 | 409 | $6.61 | $7,365 |
| 85025 Blood Count | Office | 1,113 | 409 | $7.47 | $8,318 |
| 84443 Clinical Chemistry | Office | 1,113 | 409 | $16.16 | $18K |
| 84550 Clinical Chemistry | Office | 1,112 | 408 | $4.35 | $4,841 |
| 85379 Clinical Chemistry | Office | 1,112 | 411 | $9.81 | $11K |
| 83036 Blood Count | Office | 1,105 | 409 | $9.35 | $10K |
| 80061 Clinical Chemistry | Office | 1,087 | 408 | $12.89 | $14K |
By year: 2022 $669K for 22,060 services; 2023 $685K for 23,667 services; 2024 $572K for 22,706 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80048 Clinical Chemistry | 1,116 | 409 | $8.16 | $9,104 |
| 84484 Clinical Chemistry | 1,115 | 408 | $11.99 | $13K |
| 82553 Clinical Chemistry | 1,115 | 408 | $11.11 | $12K |
| 80076 Clinical Chemistry | 1,115 | 409 | $7.88 | $8,787 |
| 84436 Clinical Chemistry | 1,114 | 409 | $6.61 | $7,365 |
| 83880 Clinical Chemistry | 1,114 | 408 | $37.87 | $42K |
| 85025 Blood Count | 1,113 | 409 | $7.47 | $8,318 |
| 84443 Clinical Chemistry | 1,113 | 409 | $16.16 | $18K |
| 84550 Clinical Chemistry | 1,112 | 408 | $4.35 | $4,841 |
| 85379 Clinical Chemistry | 1,112 | 411 | $9.81 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Ayman Karkoutly prescribed most often to Medicare patients was Ranolazine Er (Ranolazine), with 960 prescriptions and refills. In total Ayman Karkoutly wrote 10,430 Medicare prescriptions that cost $767K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ranolazine Er Ranolazine | 960 | 2,185 | 254 | $61K |
| Metoprolol Tartrate Generic | 900 | 2,230 | 239 | $3,949 |
| Clopidogrel Clopidogrel Bisulfate | 783 | 2,084 | 214 | $9,177 |
| Furosemide Generic | 513 | 1,276 | 158 | $2,644 |
| Metoprolol Succinate Generic | 510 | 1,275 | 139 | $6,695 |
| Potassium Chloride Generic | 425 | 1,014 | 128 | $8,538 |
| Rosuvastatin Calcium Generic | 364 | 942 | 98 | $4,500 |
| Atorvastatin Calcium Generic | 264 | 624 | 69 | $2,287 |
| Simvastatin Generic | 228 | 642 | 66 | $1,605 |
| Pentoxifylline Generic | 227 | 468 | 59 | $5,241 |
| Carvedilol Generic | 212 | 479 | 62 | $1,156 |
| Digoxin Generic | 212 | 547 | 66 | $5,174 |
| Amlodipine Besylate Generic | 205 | 541 | 59 | $1,271 |
| Eliquis Apixaban | 203 | 326 | 45 | $165K |
| Amiodarone Hcl Generic | 175 | 345 | 53 | $5,079 |
Brand drugs: 875 claims; generic drugs: 9,542 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ayman Karkoutly $336 ($336 in general payments such as food, travel and fees) from 7 companies. The largest payer was Medtronic, Inc. with $94.19.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.